References
- Kolek V. Chronic cough, cause, diagnosis, treatment. Vltavín. 2000
- van Schaik S M, Tristam D A, Nagpal I S, Hintz K M, Welliever R C, II, Welliever R C. Increased production of IFN‐gamma and cysteinyl leukotrienes in virus‐induced wheezing. J Allergy Clin Immunol 1999; 103: 630–636, [PUBMED], [INFOTRIEVE]
- Global strategy for asthma management and prevention. Global initiative for asthma, NHLBI/WHO. NIH Publication No. 02‐3659. 2002
- Ayik S O, Basoglu O K, Erdinc M, Bor S, Veral A, Bilgen C. Eosinophilic bronchitis as a cause of chronic cough. Respir Med 2003; 97: 695–701, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zápalka M, Kopřiva F, Szotkowská J. One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromones with serum ECP, FEV1, total IgE and blood eosinophil count—the influence of different therapy. Alergie 2003; 5(suppl 1)32–38
- Hay D, Trophy T J, Undem B J. Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol Sci 1995; 6: 304–309, [CROSSREF]
- Sarau M H, Ames R S, Chmabers J, Ellis C, Elshourbagy N, Foley J J, Schmidt D B, Muccitelli R M, Jenkins O, Murdock P R, Herrity N C, Halsey W, Sathe G, Muir A I, Nuthulaganti P, Dytko G M, Buckley P T, Wilson S, Bergggsma D J, Hay D WP. Identification, molecular cloning, expression, and characterization of cysteinyl leukotriene receptor. Mol Pharmacol 1999; 56: 657–663, [PUBMED], [INFOTRIEVE]
- Ravasi S, Capra V, Panigalli T, Rovati G E, Micosia S. Pharmacological differences among CysLT1 receptor antagonists with respect to LTC4 and LTD4 in human lung parenchyma. Biochem Pharmacol 2002; 63: 1537–1546, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sjoström M, Jakobsson P‐J, Juremalm M, Ahmed A, Nilssom G, Macchia L, Haeggstrom J Z. Human mast cells express two leukotriene C4 isoenzymes and the CysLT1 receptor. Biochim Biophys Acta 2002; 1583: 53–62
- Figueroa D, Breyer R M, Defoe S K, Kargman S, Daugherty B L, Waldburger K, Liu Q, Clements M, Zeng Z, O'Neill G P, Jones T R, Lynch L R, Austin C HP, Evans J F. Expression of the cysteinyl leukotriene l receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 2001; 163: 226–233, [PUBMED], [INFOTRIEVE]
- Bisgaard H. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am Rev Respir Crit Care Med 2003; 167: 379–383, [CROSSREF]
- Irwin R S, Curley F J, French C L. Chronic cough: the spectrum and frequency of the diagnosis evaluation and outcomes of specific therapy. Am Rev Respir Dis 1990; 141: 640–647, [PUBMED], [INFOTRIEVE]
- Fujimura M, Nishizawa Y, Nitshitsuji M, Abo M, Kita T, Nomura S. Longitudinal decline in pulmonary function in atopic cough and cough variant asthma. Clin Exp Allergy 2003; 33: 588–594, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dicpinigaitis P V, Dobkin J B, Reichel J. Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough‐variant asthma. J Asthma 2002; 39: 291–297, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kopřiva F, Sobolová L, Szotkowská J, Zápalka M. Treatment of chronic cough in children with montelukast, a leukotriene receptor antagonist. Clin Farmacol 2003; 1: 43–47